{"description":"Serious adverse events are defined as treatment-related adverse events of grade 3 or higher. Other adverse events are treatment-related adverse events not included in serious adverse events.\n\nOnly patients who started protocol therapy are included in the analysis of adverse events. All registered patients are included in the analysis of all-cause mortality.","eventGroups":[{"deathsNumAffected":7,"deathsNumAtRisk":44,"description":"Patients receive lenalidomide PO QD on days 1-21. Cycles repeat every 28 days in the absence of disease progression or unacceptable toxicity.","id":"EG000","otherNumAffected":14,"otherNumAtRisk":44,"seriousNumAffected":23,"seriousNumAtRisk":44,"title":"Arm A (Lenalidomide; Phase II)"},{"deathsNumAffected":2,"deathsNumAtRisk":90,"description":"Patients receive lenalidomide PO QD on days 1-21. Cycles repeat every 28 days in the absence of disease progression or unacceptable toxicity.","id":"EG001","otherNumAffected":20,"otherNumAtRisk":88,"seriousNumAffected":40,"seriousNumAtRisk":88,"title":"Arm A (Lenalidomide; Phase III)"},{"deathsNumAffected":4,"deathsNumAtRisk":92,"description":"Patients undergo observation until progression to symptomatic myeloma.","id":"EG002","otherNumAffected":5,"otherNumAtRisk":86,"seriousNumAffected":8,"seriousNumAtRisk":86,"title":"Arm B (Observation; Phase III)"}],"frequencyThreshold":"5","otherEvents":[{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Blood and lymphatic system disorders","sourceVocabulary":"CTCAE 4.0","stats":[{"groupId":"EG000","numAffected":6,"numAtRisk":44},{"groupId":"EG001","numAffected":5,"numAtRisk":88},{"groupId":"EG002","numAffected":2,"numAtRisk":86}],"term":"Anemia"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"General disorders","sourceVocabulary":"CTCAE 4.0","stats":[{"groupId":"EG000","numAffected":4,"numAtRisk":44},{"groupId":"EG001","numAffected":9,"numAtRisk":88},{"groupId":"EG002","numAffected":2,"numAtRisk":86}],"term":"Fatigue"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Gastrointestinal disorders","sourceVocabulary":"CTCAE 4.0","stats":[{"groupId":"EG000","numAffected":2,"numAtRisk":44},{"groupId":"EG001","numAffected":7,"numAtRisk":88},{"groupId":"EG002","numAffected":1,"numAtRisk":86}],"term":"Constipation"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Investigations","sourceVocabulary":"CTCAE 4.0","stats":[{"groupId":"EG000","numAffected":3,"numAtRisk":44},{"groupId":"EG001","numAffected":4,"numAtRisk":88},{"groupId":"EG002","numAffected":2,"numAtRisk":86}],"term":"Lymphocyte count decreased"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Investigations","sourceVocabulary":"CTCAE 4.0","stats":[{"groupId":"EG000","numAffected":5,"numAtRisk":44},{"groupId":"EG001","numAffected":8,"numAtRisk":88},{"groupId":"EG002","numAffected":1,"numAtRisk":86}],"term":"Neutrophil count decreased"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Investigations","sourceVocabulary":"CTCAE 4.0","stats":[{"groupId":"EG000","numAffected":5,"numAtRisk":44},{"groupId":"EG001","numAffected":5,"numAtRisk":88},{"groupId":"EG002","numAffected":1,"numAtRisk":86}],"term":"Platelet count decreased"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Investigations","sourceVocabulary":"CTCAE 4.0","stats":[{"groupId":"EG000","numAffected":6,"numAtRisk":44},{"groupId":"EG001","numAffected":9,"numAtRisk":88},{"groupId":"EG002","numAffected":2,"numAtRisk":86}],"term":"White blood cell decreased"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Skin and subcutaneous tissue disorders","sourceVocabulary":"CTCAE 4.0","stats":[{"groupId":"EG000","numAffected":4,"numAtRisk":44},{"groupId":"EG001","numAffected":1,"numAtRisk":88},{"groupId":"EG002","numAffected":1,"numAtRisk":86}],"term":"Rash maculo-papular"}],"seriousEvents":[{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Ear and labyrinth disorders","sourceVocabulary":"CTCAE 4.0","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":44},{"groupId":"EG001","numAffected":0,"numAtRisk":88},{"groupId":"EG002","numAffected":0,"numAtRisk":86}],"term":"Hearing impaired"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Ear and labyrinth disorders","sourceVocabulary":"CTCAE 4.0","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":44},{"groupId":"EG001","numAffected":1,"numAtRisk":88},{"groupId":"EG002","numAffected":0,"numAtRisk":86}],"term":"Vertigo"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Blood and lymphatic system disorders","sourceVocabulary":"CTCAE 4.0","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":44},{"groupId":"EG001","numAffected":2,"numAtRisk":88},{"groupId":"EG002","numAffected":0,"numAtRisk":86}],"term":"Febrile neutropenia"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Blood and lymphatic system disorders","sourceVocabulary":"CTCAE 4.0","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":44},{"groupId":"EG001","numAffected":1,"numAtRisk":88},{"groupId":"EG002","numAffected":0,"numAtRisk":86}],"term":"Blood and lymphatic disorders - Other"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Cardiac disorders","sourceVocabulary":"CTCAE 4.0","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":44},{"groupId":"EG001","numAffected":0,"numAtRisk":88},{"groupId":"EG002","numAffected":0,"numAtRisk":86}],"term":"Myocardial infarction"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"General disorders","sourceVocabulary":"CTCAE 4.0","stats":[{"groupId":"EG000","numAffected":5,"numAtRisk":44},{"groupId":"EG001","numAffected":5,"numAtRisk":88},{"groupId":"EG002","numAffected":0,"numAtRisk":86}],"term":"Fatigue"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Skin and subcutaneous tissue disorders","sourceVocabulary":"CTCAE 4.0","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":44},{"groupId":"EG001","numAffected":1,"numAtRisk":88},{"groupId":"EG002","numAffected":0,"numAtRisk":86}],"term":"Erythroderma"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Skin and subcutaneous tissue disorders","sourceVocabulary":"CTCAE 4.0","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":44},{"groupId":"EG001","numAffected":0,"numAtRisk":88},{"groupId":"EG002","numAffected":0,"numAtRisk":86}],"term":"Pruritus"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Skin and subcutaneous tissue disorders","sourceVocabulary":"CTCAE 4.0","stats":[{"groupId":"EG000","numAffected":2,"numAtRisk":44},{"groupId":"EG001","numAffected":2,"numAtRisk":88},{"groupId":"EG002","numAffected":0,"numAtRisk":86}],"term":"Rash maculo-papular"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Gastrointestinal disorders","sourceVocabulary":"CTCAE 4.0","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":44},{"groupId":"EG001","numAffected":1,"numAtRisk":88},{"groupId":"EG002","numAffected":0,"numAtRisk":86}],"term":"Constipation"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Gastrointestinal disorders","sourceVocabulary":"CTCAE 4.0","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":44},{"groupId":"EG001","numAffected":3,"numAtRisk":88},{"groupId":"EG002","numAffected":1,"numAtRisk":86}],"term":"Diarrhea"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Gastrointestinal disorders","sourceVocabulary":"CTCAE 4.0","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":44},{"groupId":"EG001","numAffected":1,"numAtRisk":88},{"groupId":"EG002","numAffected":0,"numAtRisk":86}],"term":"Vomiting"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Gastrointestinal disorders","sourceVocabulary":"CTCAE 4.0","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":44},{"groupId":"EG001","numAffected":1,"numAtRisk":88},{"groupId":"EG002","numAffected":0,"numAtRisk":86}],"term":"Gastrointestinal disorders - Other"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Hepatobiliary disorders","sourceVocabulary":"CTCAE 4.0","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":44},{"groupId":"EG001","numAffected":0,"numAtRisk":88},{"groupId":"EG002","numAffected":0,"numAtRisk":86}],"term":"Cholecystitis"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Immune system disorders","sourceVocabulary":"CTCAE 4.0","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":44},{"groupId":"EG001","numAffected":0,"numAtRisk":88},{"groupId":"EG002","numAffected":0,"numAtRisk":86}],"term":"Allergic reaction"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Infections and infestations","sourceVocabulary":"CTCAE 4.0","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":44},{"groupId":"EG001","numAffected":1,"numAtRisk":88},{"groupId":"EG002","numAffected":0,"numAtRisk":86}],"term":"Lung infection"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Infections and infestations","sourceVocabulary":"CTCAE 4.0","stats":[{"groupId":"EG000","numAffected":2,"numAtRisk":44},{"groupId":"EG001","numAffected":0,"numAtRisk":88},{"groupId":"EG002","numAffected":0,"numAtRisk":86}],"term":"Sepsis"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Infections and infestations","sourceVocabulary":"CTCAE 4.0","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":44},{"groupId":"EG001","numAffected":0,"numAtRisk":88},{"groupId":"EG002","numAffected":0,"numAtRisk":86}],"term":"Skin infection"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Investigations","sourceVocabulary":"CTCAE 4.0","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":44},{"groupId":"EG001","numAffected":0,"numAtRisk":88},{"groupId":"EG002","numAffected":1,"numAtRisk":86}],"term":"Creatinine increased"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Investigations","sourceVocabulary":"CTCAE 4.0","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":44},{"groupId":"EG001","numAffected":0,"numAtRisk":88},{"groupId":"EG002","numAffected":0,"numAtRisk":86}],"term":"Lymphocyte count decreased"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Investigations","sourceVocabulary":"CTCAE 4.0","stats":[{"groupId":"EG000","numAffected":7,"numAtRisk":44},{"groupId":"EG001","numAffected":12,"numAtRisk":88},{"groupId":"EG002","numAffected":1,"numAtRisk":86}],"term":"Neutrophil count decreased"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Investigations","sourceVocabulary":"CTCAE 4.0","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":44},{"groupId":"EG001","numAffected":1,"numAtRisk":88},{"groupId":"EG002","numAffected":0,"numAtRisk":86}],"term":"Platelet count decreased"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Investigations","sourceVocabulary":"CTCAE 4.0","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":44},{"groupId":"EG001","numAffected":1,"numAtRisk":88},{"groupId":"EG002","numAffected":0,"numAtRisk":86}],"term":"Weight loss"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Investigations","sourceVocabulary":"CTCAE 4.0","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":44},{"groupId":"EG001","numAffected":1,"numAtRisk":88},{"groupId":"EG002","numAffected":0,"numAtRisk":86}],"term":"White blood cell decreased"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Metabolism and nutrition disorders","sourceVocabulary":"CTCAE 4.0","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":44},{"groupId":"EG001","numAffected":1,"numAtRisk":88},{"groupId":"EG002","numAffected":0,"numAtRisk":86}],"term":"Dehydration"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Metabolism and nutrition disorders","sourceVocabulary":"CTCAE 4.0","stats":[{"groupId":"EG000","numAffected":2,"numAtRisk":44},{"groupId":"EG001","numAffected":0,"numAtRisk":88},{"groupId":"EG002","numAffected":0,"numAtRisk":86}],"term":"Hypokalemia"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Metabolism and nutrition disorders","sourceVocabulary":"CTCAE 4.0","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":44},{"groupId":"EG001","numAffected":0,"numAtRisk":88},{"groupId":"EG002","numAffected":2,"numAtRisk":86}],"term":"Hyponatremia"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Musculoskeletal and connective tissue disorders","sourceVocabulary":"CTCAE 4.0","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":44},{"groupId":"EG001","numAffected":0,"numAtRisk":88},{"groupId":"EG002","numAffected":0,"numAtRisk":86}],"term":"Back pain"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Musculoskeletal and connective tissue disorders","sourceVocabulary":"CTCAE 4.0","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":44},{"groupId":"EG001","numAffected":2,"numAtRisk":88},{"groupId":"EG002","numAffected":0,"numAtRisk":86}],"term":"Myalgia"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Nervous system disorders","sourceVocabulary":"CTCAE 4.0","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":44},{"groupId":"EG001","numAffected":1,"numAtRisk":88},{"groupId":"EG002","numAffected":0,"numAtRisk":86}],"term":"Ataxia"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Nervous system disorders","sourceVocabulary":"CTCAE 4.0","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":44},{"groupId":"EG001","numAffected":0,"numAtRisk":88},{"groupId":"EG002","numAffected":0,"numAtRisk":86}],"term":"Dizziness"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Nervous system disorders","sourceVocabulary":"CTCAE 4.0","stats":[{"groupId":"EG000","numAffected":2,"numAtRisk":44},{"groupId":"EG001","numAffected":0,"numAtRisk":88},{"groupId":"EG002","numAffected":0,"numAtRisk":86}],"term":"Headache"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Nervous system disorders","sourceVocabulary":"CTCAE 4.0","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":44},{"groupId":"EG001","numAffected":0,"numAtRisk":88},{"groupId":"EG002","numAffected":1,"numAtRisk":86}],"term":"Paresthesia"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Nervous system disorders","sourceVocabulary":"CTCAE 4.0","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":44},{"groupId":"EG001","numAffected":0,"numAtRisk":88},{"groupId":"EG002","numAffected":0,"numAtRisk":86}],"term":"Peripheral motor neuropathy"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Nervous system disorders","sourceVocabulary":"CTCAE 4.0","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":44},{"groupId":"EG001","numAffected":2,"numAtRisk":88},{"groupId":"EG002","numAffected":0,"numAtRisk":86}],"term":"Peripheral sensory neuropathy"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Nervous system disorders","sourceVocabulary":"CTCAE 4.0","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":44},{"groupId":"EG001","numAffected":1,"numAtRisk":88},{"groupId":"EG002","numAffected":0,"numAtRisk":86}],"term":"Syncope"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Nervous system disorders","sourceVocabulary":"CTCAE 4.0","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":44},{"groupId":"EG001","numAffected":0,"numAtRisk":88},{"groupId":"EG002","numAffected":0,"numAtRisk":86}],"term":"Nervous system disorders - Other"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)","sourceVocabulary":"CTCAE 4.0","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":44},{"groupId":"EG001","numAffected":2,"numAtRisk":88},{"groupId":"EG002","numAffected":0,"numAtRisk":86}],"term":"Treatment related secondary malignancy"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Psychiatric disorders","sourceVocabulary":"CTCAE 4.0","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":44},{"groupId":"EG001","numAffected":1,"numAtRisk":88},{"groupId":"EG002","numAffected":0,"numAtRisk":86}],"term":"Confusion"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Psychiatric disorders","sourceVocabulary":"CTCAE 4.0","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":44},{"groupId":"EG001","numAffected":1,"numAtRisk":88},{"groupId":"EG002","numAffected":0,"numAtRisk":86}],"term":"Insomnia"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Respiratory, thoracic and mediastinal disorders","sourceVocabulary":"CTCAE 4.0","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":44},{"groupId":"EG001","numAffected":3,"numAtRisk":88},{"groupId":"EG002","numAffected":0,"numAtRisk":86}],"term":"Dyspnea"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Renal and urinary disorders","sourceVocabulary":"CTCAE 4.0","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":44},{"groupId":"EG001","numAffected":0,"numAtRisk":88},{"groupId":"EG002","numAffected":1,"numAtRisk":86}],"term":"Acute kidney injury"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Renal and urinary disorders","sourceVocabulary":"CTCAE 4.0","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":44},{"groupId":"EG001","numAffected":0,"numAtRisk":88},{"groupId":"EG002","numAffected":1,"numAtRisk":86}],"term":"Chronic kidney disease"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Renal and urinary disorders","sourceVocabulary":"CTCAE 4.0","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":44},{"groupId":"EG001","numAffected":0,"numAtRisk":88},{"groupId":"EG002","numAffected":0,"numAtRisk":86}],"term":"Renal and urinary disorders - Other"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Vascular disorders","sourceVocabulary":"CTCAE 4.0","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":44},{"groupId":"EG001","numAffected":1,"numAtRisk":88},{"groupId":"EG002","numAffected":2,"numAtRisk":86}],"term":"Hypertension"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Vascular disorders","sourceVocabulary":"CTCAE 4.0","stats":[{"groupId":"EG000","numAffected":2,"numAtRisk":44},{"groupId":"EG001","numAffected":1,"numAtRisk":88},{"groupId":"EG002","numAffected":0,"numAtRisk":86}],"term":"Thromboembolic event"}],"timeFrame":"Assessed every 4 weeks while on treatment and for 30 days after the end of treatment, up to 10 years"}